- CLINICAL CORE The Clinical Core will establish and maintain a cohort of extensively characterized individuals who have volunteered to participate in research projects addressing brain aging and dementia. In addition to serving the national NIA mandates related to Alzheimer?s disease, Clinical Core resources will be distributed and adjusted to support intramural research programs investigating the heterogeneity of cognitive aging and dementia, as reflected in the themes of unusually successful brain aging (SuperAging) and non-amnestic dementias (e.g., primary progressive aphasia). The emphasis on Alzheimer?s disease will shift to earlier and pre-symptomatic stages with a view toward prevention trials. The SuperAging projects will explore factors that promote resilience to aging-related involutional changes and resistance to the emergence of Alzheimer pathology. The primary progressive aphasia program will help to clarify the biological diversity of Alzheimer?s disease and the principles of selective vulnerability in focal brain neurodegeneration. In the next five years, the Clinical Core will support the following goals: 1. Maintain a diverse cohort of 500 research participants that will include cognitively healthy persons with or without subjective complaints of memory impairment and individuals with different forms of amnestic and non- amnestic deficits. These subjects will be characterized by the Uniform Data Set (UDS), followed annually, and committed to research participation, tissue donation and contribution to national collaborations through NACC, ADCS, ADGC, NCRAD, and ADNI. 2. Emphasize the recruitment of study participants for areas of research where the Northwestern ADC enjoys a national leadership role, such as SuperAging, primary progressive aphasia (PPA) and other dementias caused by frontotemporal diseases. 3. Promote the ?therapeutic encounter? theme of the ADC through the support of innovative non- pharmacologic interventions that target unique person-specific symptom profiles. 4. Sustain a training approach that capitalizes on the multidisciplinary ?centerness? of the Northwestern ADC and that serves the mission of the Research Education Component through the cultivation of an environment where trainees from different disciplines (basic and cognitive science, neurology, neuropsychology, psychiatry, social work, and neuroimaging) train together in contiguous space.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013854-25
Application #
9973049
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
25
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Ohm, D T; Kim, G; Gefen, T et al. (2018) Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia. Neuropathol Appl Neurobiol :
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Tirrell, Timothy F; Rademaker, Alfred W; Lieber, Richard L (2018) Analysis of hierarchical biomechanical data structures using mixed-effects models. J Biomech 69:34-39
Gefen, Tamar; Ahmadian, Saman S; Mao, Qinwen et al. (2018) Combined Pathologies in FTLD-TDP Types A and C. J Neuropathol Exp Neurol 77:405-412
Raghanti, Mary Ann; Edler, Melissa K; Stephenson, Alexa R et al. (2018) A neurochemical hypothesis for the origin of hominids. Proc Natl Acad Sci U S A 115:E1108-E1116
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679

Showing the most recent 10 out of 443 publications